HomeAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
$27.14
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$27.14
Sarado: Abr 16, 4:02:32 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$27.82
Sakop ng araw
$26.87 - $27.74
Sakop ng taon
$23.42 - $62.58
Market cap
1.56B USD
Average na Volume
704.96K
P/E ratio
2.33
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 10.73M | 51.06% |
Gastos sa pagpapatakbo | 51.70M | 46.43% |
Net na kita | -96.52M | -0.61% |
Net profit margin | -899.56 | 33.40% |
Kita sa bawat share | -1.74 | -1.16% |
EBITDA | -123.67M | -17.92% |
Aktuwal na % ng binabayarang buwis | 8.42% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 893.71M | 15.03% |
Kabuuang asset | 1.66B | 77.48% |
Kabuuang sagutin | 122.24M | -3.06% |
Kabuuang equity | 1.54B | — |
Natitirang share | 57.30M | — |
Presyo para makapag-book | 1.03 | — |
Return on assets | -18.09% | — |
Return on capital | -19.03% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -96.52M | -0.61% |
Cash mula sa mga operasyon | -133.17M | -83.71% |
Cash mula sa pag-invest | -49.16M | -151.47% |
Cash mula sa financing | 4.84M | 471.66% |
Net change in cash | -177.48M | -843.48% |
Malayang cash flow | -108.06M | -155.48% |
Tungkol
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Itinatag
2008
Website
Mga Empleyado
487
